Recombinant anti-FRMD4A intrabody in fusion with HIV Tat works within cells to direct against human FRMD4A, expressed in CHO cells. The intrabody can be used in therapeutic methods for treating proliferative disorders, including squamous cell carcinoma (SCC).
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
IAB-B059(A) | Recombinant Anti-human FRMD4A Intrabody [(D-Arg)9] | CO-IP, FuncS | scFv-(D-Arg)9 |
IAB-B059(G) | Recombinant Anti-human FRMD4A Intrabody [+36 GFP] | ELISA, IF, Neut, FuncS | scFv-(+36GFP) |
There are currently no Customer reviews or questions for IAB-B059(T). Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.